The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs
HI Bax, IAJM Bakker-Woudenberg, CP de Vogel… - Tuberculosis, 2017 - Elsevier
Novel treatment strategies for tuberculosis are urgently needed. Many different preclinical
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs
HI Bax, IAJM Bakker-Woudenberg… - Tuberculosis …, 2017 - pubmed.ncbi.nlm.nih.gov
Novel treatment strategies for tuberculosis are urgently needed. Many different preclinical
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs
H Bax, I Bakker-Woudenberg, C de Vogel… - Tuberculosis, 2017 - repub.eur.nl
Novel treatment strategies for tuberculosis are urgently needed. Many different preclinical
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
The role of the time-kill kinetics assay as part of a preclinical modeling framework for assessing the activity of anti-tuberculosis drugs.
HI Bax, I Bakker-Woudenberg, CP de Vogel… - Tuberculosis …, 2017 - europepmc.org
Novel treatment strategies for tuberculosis are urgently needed. Many different preclinical
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …
models assessing anti-tuberculosis drug activity are available, but it is yet unclear which …